|
|
Chunghwa Chemical Synthesis & Biotech Co Ltd
TAI •
Healthcare •
Biotechnology •
Quote as of 06/08/2026 13:30
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeTAI
Market Capitalization3,069.03 mln
Float33.24 mln
Relative Strength
51
/ 100
In line with market
Key Fundamentals
EPS-4.39
ROE-7.48
RPS14.47
ROIC-7.22
ROA-5.33
EBITDA, mln-47.60
EV / EBITDA-58.11
EV / EBIT-11.58
Revenue, mln805
EV / Revenue3.44
Financial Strength
Altman Z-Score1.71
Piotroski F-Score
4
/ 9
Beneish M-Score-17.95
Price to Intrinsic Value0.85
Shiller PE Ratio13.41
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
4% |
86
/ 100
 |
| 1 Month |
4% |
67
/ 100
 |
| 2 Months |
48.71% |
90
/ 100
 |
| 6 Months |
64.49% |
83
/ 100
 |
| 1 Year |
38.49% |
74
/ 100
 |
|
| |
